Antibody Drug Conjugates Market Size is Expected to Reach USD 25.38 Billion by 2033, Growing at a CAGR of 8.84%: Straits ResearchGlobeNewsWire • 01/22/25
AbbVie's stock dips premarket after it lowers Q1 guidance to reflect dilutive impact of ImmunoGen deal closeMarket Watch • 02/12/24
Is ImmunoGen (IMGN) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 02/09/24
ImmunoGen (IMGN) Soars 5.7%: Is Further Upside Left in the Stock?Zacks Investment Research • 02/09/24
All You Need to Know About ImmunoGen (IMGN) Rating Upgrade to Strong BuyZacks Investment Research • 01/04/24
ImmunoGen Presents Findings from Newly Diagnosed Acute Myeloid Leukemia Cohorts in Phase 1b/2 Study of Pivekimab Sunirine in Combination with Azacitidine and Venetoclax at ASHBusiness Wire • 12/10/23
FDA Grants Priority Review of ImmunoGen's Supplemental Biologics License Application for ELAHERE® (mirvetuximab soravtansine-gynx) in Platinum-Resistant Ovarian CancerBusiness Wire • 12/05/23
IMMUNOGEN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ImmunoGen, Inc. - IMGNBusiness Wire • 12/05/23
Are You Looking for a Top Momentum Pick? Why ImmunoGen (IMGN) is a Great ChoiceZacks Investment Research • 12/04/23